(Incorporated in the Cayman Islands)

We are a newly organized blank check company, also known as a SPAC. We have not selected a target sector or region.

Wei Qian, our Chairman, Chief Executive Officer and Chief Financial Officer, has served as the Director of Capital Markets at Fusion Park, LLC, a US-based firm specializing in climate change tech investments and consulting, since March 2023. He has also been Chief Executive Officer, Chief Financial Officer and a director of Piermont Valley Acquisition Corp, a SPAC that is searching for a target business with which to complete an initial business combination, since July 2025. Mr. Qian’s past roles include serving as General Manager in the New York office of Cathay Holding Corp., a private equity firm, from May 2021 to March 2023; as Interim CEO of Hemp Logic Inc., a US-based CBD company to spearhead its expansion in China, from August 2020 to May 2021; as Director of Investment at Xingtong Capital, an investment fund within the Shanshan Group, from July 2015 to July 2017; and as Vice Director of Investment at Transfar Holding Group, an investment company within Transfar Group, from July 2017 to August 2018. Mr. Qian’s career began in 2011 and he has had experience in private equity and venture capital, focusing on technology, media and telecommunications (“TMT”), healthcare, and climate tech sectors. Mr. Qian served as an independent director of Battery Future Acquisition Corp., a SPAC that completed its initial business combination with Class Over Inc., an online education provider, from March 2024 to March 2025. 

Yan Zhang has served as the president and the director of Lion Group Holding Ltd. (Nasdaq: LGHL), an online trading platform company, since May 2021, and she conducted her own financial consulting services from July 2020 to April 2021. From September 2009 to June 2020, Ms. Zhang served as a manager, senior manager, and subsequently, principal of UHY Advisors NY, Inc., an accounting firm. From 2004 to 2007, Ms. Zhang served as a senior accountant of PricewaterhouseCoopers LLP in Beijing, China.

Yao Guo has served as Vice President of Business Analytics at Panera Bread, a fast-casual restaurant chain, where he oversees enterprise business analytics and strategy in support of the company’s transformation initiatives, since November 2025. From March 2023 to October 2025, Mr. Guo served as Senior Director of Strategy & Analytics at Subway, a global quick-service restaurant brand. In this role, he led the business analytics, sales planning, restaurant operations analytics, franchisee profitability, development analytics, and market planning functions globally. Prior to Subway, Mr. Guo was Senior Director of Global Sales & Demand Planning at Frida, a consumer packaged goods company, from July 2021 to March 2023. From July 2015 to July 2021, Mr. Guo spent six years at Restaurant Brands International, a global quick-service restaurant company whose portfolio includes Burger King, Popeyes, Tim Hortons, and Firehouse Subs.

Xiao Wu has been an assistant professor of Biostatistics in the Department of Biostatistics at Columbia University Mailman School of Public Health and a member of the Columbia Data Science Institute since January 2023. He is a nationally recognized quantitative researcher whose work spans causal inference, statistical learning, data science, wearable health AI, and environmental health. During his career, Dr. Wu has served as Principal Investigator for multiple federally funded research programs, including competitive research and career development awards from the National Institutes of Health (NIH). Through these programs, he has overseen multi-institution collaborations, managed multi-year grants, ensured regulatory and data-governance compliance, and delivered scientific evidence, technology development, and long-term strategic planning. In addition to his academic leadership, Dr. Wu has been a quantitative scientist at Meta Platforms Inc. since June 2025. He has been named to Forbes 30 Under 30 list in Healthcare. His research has been published in prestigious scientific venues such as Science, New England Journal of Medicine, and Lancet Planetary Health, and it has been referenced in international journalism, including at the New York Times, the Guardian, National Geographic, Scientific American, and Financial Times.

(Note: Pine Tree Acquisition Corp. filed the S-1 for its SPAC IPO on Dec. 19, 2025, and disclosed the terms: 10 million units at $10.00 each to raise $100 million. Each unit consists of one share of stock and one right to receive one-tenth of a share upon the completion of an initial business combination.)